RecruitingNot ApplicableNCT03825575
Sacral Neuromodulation as Treatment for Fecal Incontinence
Sponsor
McMaster University
Enrollment
20 participants
Start Date
Sep 8, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
The objective of this study is to investigate if low level laser therapy will do more good than harm for patients with severe refractory fecal incontinence. It is a proof of concept study without a placebo arm.
Eligibility
Min Age: 6 YearsMax Age: 80 Years
Inclusion Criteria1
- Patients with fecal incontinence
Exclusion Criteria7
- Pregnant patients
- Known malignancies in the area of treatment
- Active bleeding in area of treatment
- Active deep vein thrombosis
- When tatoos are present at area of treatment
- Patients that are light sensitive
- Patients who take steroids.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICELow level laser therapy (LLLT)
A 3 week treatment period with a total of 8 treatments of 1 hour over the sacral spinal cord
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03825575
Related Trials
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
NCT052009237 locations
Autologous Muscle Fiber Fragment Injections
NCT053964561 location
Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)
NCT060915663 locations
Mechanisms of Action on Rectal Motricity of Intrarectal Botulinum Toxin Injections
NCT059981871 location
Acute Genital Nerve Stimulation for Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury
NCT056268161 location